| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |